drugset / Trial / NCT03590444
Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser
RandomizedParallel-groupOpen-labelTreatment
Summary
Long-term follow-up of patients with diabetic macular edema (DME) treated with intravitreal anti-vascular endothelial growth factor (anti-VEGF) combined focal laser and identification of prognostic morphological characteristics.
Timeline
- Start
- 2017-04-02
- Primary completion
- 2018-04-02
- Completion
- 2018-06-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ranibizumab | Monoclonal antibody | 0.5 mg | — |